Skip to content
Solid Ideas

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Deal Because of Data Apprehensions

Medical aid image
The offered American funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a significant American healthcare agreement valued at $367m (£272m) spanning five years because of Washington's demand for confidential biological samples.

This rejection became public after a official document dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".

An official spokesman has since stated that the United States was requesting genetic material for research and commercial purposes but refused to guarantee the benefits from any future treatments.

"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged more dialogue to reach a deal acceptable to all parties so the nation's critical HIV programme can be sustained.

Wider Context

This rejection comes after a comparable case in Kenya, where a high court halted a related health funding agreement after legal challenges were filed about the security of citizens' medical information.

Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

The agency had administered assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.

According to statements, Sixteen African countries have so far agreed to similar agreements, constituting more than $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million currently on HIV treatment through American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," Mangwana explained.

"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our population if a future health crisis arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the global health body and its push of one-on-one deals were upending systems already set up through the international organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.

"This mechanism is intended to ensure that when a country provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome continued dialogue with our US partners on how subsequent co-operation might be structured in a manner that honours the sovereignty and interests of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that negotiations need to persist since much of the nation's HIV programmes were funded by foreign aid.

"If technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.

This impasse underscores the ongoing challenges between accepting vital international aid and protecting a country's data in an ever more interconnected world.

About the author

Melissa Mason

A tech strategist with over a decade of experience in digital transformation and innovation, passionate about simplifying complex tech concepts.

Solid Ideas

Type to search articles.